Special thanks to @PamelaMusaio for the book explaining Rare tumors and inclusivity to kids in the schools and thanks to @SarcomaUniTo lab for the fantastic work carried out with passion and excellence! 👏👏👏
Today we had the pleasure to host in Turin the Desmoid Foundation @DesmoidI w/ @PamelaMusaio. Morning w/ secondary school kids (inclusion/diversity project, as applied to rare tumors: we wrote a book!) + afternoon visiting our lab @SarcomaUniTo . Huge thanks for your support🙏
Great work from @FioreDoc and colleagues on pregnancy in patients with desmoids! Limited risk of progression even in patients with active disease. Really useful information for clinical practice. We’ll done!
@alegronchi@ChirSarcomi_INT@SarcomaUniTo@DesmoidI
Hybrid meetings happily still exist and although not ideal during a consensus meeting, it makes global input possible. The people behind the scene do great work to enable this. Thanks everyone! @DesmoidI#Fondazione IRCCS @IstTumori@alegronchi and Bernd Kasper
And after the successful day of the consensus meeting of desmoid tumor working group, today is the Italian desmoid patients’ day at @IstTumori @ChirSarcomi_INT Pregnancy, Surveillance, Cryotherapy, New drugs and more. @ctosociety @DesmoidI
Nel mese di dicembre 2022 la Desmoid Foundation ONLUS ha iniziato una collaborazione con Unobravo | Servizio di #psicologia online.
Il #sostegno è dedicato ai nostri #pazienti che sentivano l’esigenza di condividere e confrontarsi sulle difficoltà che il tumore #desmoide impone.
3 December - International Day of Persons with Disabilities
We are close to all patients with invisible disabilities, as all patients with #cancer.
#desmoid#tumor is a rare disease and it's often an invisible #disease. But no one has to be let alone.
Let's be kind always!
Great job Bernd! Very well presented. Nirogacestat determins 40% response rate and 70+% PFS. A new option in the medical armamentarium for #desmoid to be exploited when an active treatment is needed. Of note desmoid more often don’t need any treatment…
Thanks to Dr. Chiara Colombo and Dr. Costanza Figura for their participation at the 12th annual conference @sarcomapatients.It was a meeting full of important informations and updates for #desmoid tumor.
Thanks to Christina, Michi and all @sarcomapatients staff for organizing it!
** 𝐂𝐀𝐌𝐏𝐀𝐆𝐍𝐀 𝐒𝐎𝐂𝐈 𝟐𝟎𝟐𝟐 **
Sono aperte le iscrizioni soci per la Desmoid Foundation ONLUS, a supporto dei pazienti affetti da tumore #desmoide e Sindrome di Gardner❤️
Per saperne di più, visitate il nostro sito web:
desmoidfoundation.org#desmoid#RareDisease
#RECIST is not always the best method to measure treatment outcomes for #desmoid patients. This week, The DTRF hosted its first working group meeting with top #radiologists and pharma partners to identify other imaging features to better evaluate patient outcomes.